Promising Treatment for Aggressive Childhood Cancer
Promising Treatment for Aggressive Childhood Cancer

The latest promising treatment for aggressive childhood cancer neuroblastoma, an aggressive form of childhood cancer, is the KSP inhibitor. The study was led by researchers at Lund University in Sweden, and is published in the journal Science Translational Medicine. About 800 children in the US are diagnosed with neuroblastoma annually. Neuroblastoma is an aggressive cancer of […]

Read more
Avoiding Infection While on Treatment for Childhood Cancer

Caregivers can contribute to positive treatment outcomes by helping children with cancer avoid exposure to infections. Whenever medically advised, children should continue to participate in school and other activities to maintain relationships and build social skills. This may be hard for caregivers, who may feel more comfortable keeping a child at home to avoid exposure […]

Read more
Leukaemia Drug May Help Treating Childhood Brain Cancer

Researchers describe a new use of leukaemia drug, nilotinib, to treat a subtype of medulloblastoma, a deadly paediatric brain cancer. According to a multi-institutional team led by researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego, medication used to treat chronic myeloid leukemia could be more effective at stopping […]

Read more
Why Is Stage IV Cancer Difficult to Treat?

The more widely cancer has spread from the site where it is first diagnosed, the more difficult it becomes to treat. Cancer is labeled stage IV when it is found not only in its original location, but also in distant tissues and organs. There are several staging systems used by pathologists and cancer specialists to […]

Read more
Long-Term Cardiomyopathy Risk in Childhood Cancer Survivors

Recently, an analysis of long-term cardiomyopathy risk in 28,000 childhood cancer survivors in the US and Europe was done. Researchers compared 4 chemotherapy drugs with development of cardiomyopathy (diseases of the heart muscle). They found exposure to different anthracyclines results in different long-term cardiovascular risk. Heart disease is a leading cause of early death from non-cancer causes […]

Read more
Presence in Times of Pain

The one thing that we can all agree on is that Cancer is very painful at the best of times. Pain is very difficult to cope with both for the person fighting this dreadful disease and for anyone else in their presence in times of pain. Very often we do not know what to do […]

Read more
Why Delays to Fixing Health Care are Bad News for South Africans

The release of a final report about the state of competition in South Africa’s private health sector has been delayed again. It was compiled by an inquiry panel made up of medical, legal and economic experts. The panel heard submissions from a range of stakeholders including members of the public, civil society organisations as well […]

Read more